Status:
UNKNOWN
Autoantibodies in Patients With Type 1 Diabetes Mellitus
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
1-20 years
Brief Summary
Evaluate the autoantibodies, such as glutamic acid decarboxylase (GAD65), tyrosine phosphatase (IA-2 or ICA125), islet autoantibodies (IAA) and other associated autoimmune autoantibodies: microsomal a...
Detailed Description
Type 1 diabetes mellitus (DM) is a common disease in pediatric endocrine clinic and epidemiological studies showed the racial variation in the incidence, with the highest of 35 cases per 100000 in Fin...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- pediatric patients with type 1 diabetes
Exclusion
Key Trial Info
Start Date :
January 1 1990
Trial Type :
OBSERVATIONAL
End Date :
December 1 2006
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00173628
Start Date
January 1 1990
End Date
December 1 2006
Last Update
December 21 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan